CAS 1620401-82-2: UNC0379
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]- REF: IN-DA001SNWCAS: 1620401-82-2 | 98% | Prezzo su richiesta | Mar 04 Mar 25 |
 | UNC0379 REF: TM-T1841CAS: 1620401-82-2 | 94.41% - 99.97% | 51,00 €~354,00 € | Mar 11 Mar 25 |
 | UNC 0379 REF: 3D-FU137732CAS: 1620401-82-2 | Min. 95% | 208,00 €~503,00 € | Gio 13 Mar 25 |
![4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-](https://static.cymitquimica.com/products/IN/thumb/DA001SNW.jpg)
4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-
CAS:1620401-82-2
Formula:
C23H35N5O2
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
413.5563
Ref: IN-DA001SNW
| 1mg | 50,00 € | ||
| 5mg | 86,00 € | ||
| 10mg | 118,00 € |
Consegna stimata in Stati Uniti, il Martedì 04 Marzo 2025
UNC0379
CAS:1620401-82-2
UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
Formula:
C23H35N5O2
Purezza:
94.41% - 99.97%
Colore e forma:
Solid
Peso molecolare:
413.56
Ref: TM-T1841
| 5mg | 51,00 € | ||
| 10mg | 88,00 € | ||
| 25mg | 143,00 € | ||
| 50mg | 235,00 € | ||
| 100mg | 354,00 € | ||
| 1mL*10mM (DMSO) | 57,00 € |
Consegna stimata in Stati Uniti, il Martedì 11 Marzo 2025
UNC 0379
CAS:1620401-82-2
Inhibitor of the histone methyltransferase SETD8 that supresses methylation of the K20 residue in histone …
Formula:
C23H35N5O2
Purezza:
Min. 95%
Colore e forma:
Solid
Peso molecolare:
413.56 g/mol
Ref: 3D-FU137732
| 10mg | 208,00 € | ||
| 50mg | 503,00 € |
Consegna stimata in Stati Uniti, il Giovedì 13 Marzo 2025
